Global assessment of genetic variation influencing response to retinoid chemoprevention in head and neck cancer patients

Head and neck squamous cell carcinoma (HNSCC) patients are at an increased risk of developing a second primary tumor (SPT) or recurrence following curative treatment. 13-cis-retinoic acid (13-cRA) has been tested in chemoprevention clinical trials but the results have been inconclusive. We genotyped...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lee, J. Jack, Wu, Xifeng, Hildebrandt, Michelle A.T., Yang, Hushan, Khuri, Fadlo R., Kim, Edward, Gu, Jian, Ye, Yuanqing, Lotan, Reuben, Spitz, Margaret R., Hong, Waun Ki
Formato: Artigo
Lenguaje:Inglês
Publicado: 2011
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3955084/
https://ncbi.nlm.nih.gov/pubmed/21292633
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-10-0125
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares